New drugs for HIV therapy

被引：6

作者：

Gulick, RM

Staszewski, S

机构：

[1] Cornell Univ, Cornell Clin Trials Unit, Weill Med Coll, New York, NY 10024 USA

[2] Univ Hosp Frankfurt, Frankfurt, Germany

来源：

AIDS | 2002年 / 16卷

关键词：

antiretroviral therapy; reverse transcriptase inhibitors; protease inhibitors; entry inhibitors; integrase inhibitors;

D O I：

10.1097/00002030-200216004-00019

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

[No abstract available]

引用

页码：S135 / S144

页数：10

共 86 条

[1]

ALDROVANDI G, 2002, 9 C RETR OPP INF SEA

[2] EXPRESSION AND CHARACTERIZATION OF CD4-IGG(2), A NOVEL HETEROTETRAMER THAT NEUTRALIZES PRIMARY HIV TYPE-1 ISOLATES [J].

ALLAWAY, GP ;

DAVISBRUNO, KL ;

BEAUDRY, GA ;

GARCIA, EB ;

WONG, EL ;

RYDER, AM ;

HASEL, KW ;

GAUDUIN, MC ;

KOUP, RA ;

MCDOUGAL, JS ;

MADDON, PJ .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 (05) :533-539

[3]

BAEDE P, 2002, 42 INT C ANT AG CHEM

[4]

BAROUDY BM, 2002, 14 INT AIDS C BARC J

[5]

BAROUDY BM, 2001, 1 INT AIDS SOC C HIV

[6]

BENSON C, 2001, 41 INT C ANT AG CHEM

[7]

BETHELL RC, 2002, 9 C RETR OPP INF SEA

[8] The CXCR4 antagonist AMD3100 efficiently inhibits cell-surface-expressed human immunodeficiency virus type 1 envelope-induced apoptosis [J].

Blanco, J ;

Barretina, J ;

Henson, G ;

Bridger, G ;

De Clercq, E ;

Clotet, B ;

Esté, JA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (01) :51-56

[9]

Borroto-Esoda K, 2001, 1 IAS C HIV PATH TRE

[10]

CALVEZ V, 2002, 11 INT HIV DRUG RES

← 1 2 3 4 5 6 7 8 9 →